Retrospective evaluation of hypersensitivity reactions and anaphylaxis in dogs (2003–2014): 86 cases
Journal of Veterinary Emergency and Critical Care · 2023
DOI: 10.1111/vec.13319 ↗At a glance
Journal article in Journal of Veterinary Emergency and Critical Care, 2023. Written by Fabrice T J Fosset and 4 co-authors. Institution: NorthStar VETS, Robbinsville Twp, New Jersey, New Jersey, USA. Major MEDLINE topics: Anaphylaxis, Hypersensitivity, Hypersensitivity, Immediate, Dog Diseases. Cited 7 times so far (Crossref); 43 references.
Abstract (original language)
Objective
To characterize anaphylactic reactions in dogs, including clinical signs, severity, treatments, prognosis, and estimated incidence. To determine whether glucocorticoids influence clinical recovery and survival.
Design
Retrospective study between January 1, 2003 and April 28, 2014.
Setting
University teaching hospital. Animals Eighty‐six dogs treated for a type I hypersensitivity reaction. Nineteen dogs fulfilled the criteria for anaphylaxis, and 67 dogs had mild cutaneous reactions.
Interventions
None. Measurements and Main Results The estimated incidence was 0.04% for anaphylaxis and 0.15% for mild hypersensitivity reactions. The female:male ratio (2.3:1) was significantly higher ( P = 0.032) compared to our source population (ratio of 1:1.158). Vaccines were the most frequent trigger for anaphylaxis (57.9%) and mild hypersensitivity reactions (28.4%). Seventy‐four (86%) dogs had cutaneous signs, and 11 (57.9%) dogs with anaphylaxis had no cutaneous signs reported. Forty‐two (48.8%) dogs received both an H1 antagonist and a glucocorticoid, 34 (39.5%) dogs received an H1 antagonist only, and 6 (6.9%) dogs received a glucocorticoid only. The majority of the dogs survived, and 1 was euthanized due to complications. Clinical signs associated with nonsurvival included respiratory signs ( P = 0.006), particularly respiratory distress ( P < 0.00001) and cyanosis ( P < 0.00001), and circulatory shock ( P = 0.005). The analysis of the interaction between etiology, clinical signs, treatment, and outcome did not show any association between pairs of variables.
Conclusions
In the current study, anaphylaxis had a relatively good prognosis, and cutaneous signs were not always present. Based on the present data, the use of glucocorticoids to treat mild type I hypersensitivity reactions and anaphylaxis in dogs was not associated with clinical improvement or survival.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- NorthStar VETS, Robbinsville Twp, New Jersey, New Jersey, USA.
- Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois, Urbana, Illinois, USA.
- Environmental Science, Adelphi University, Garden City, New York, USA.
- NVA Midwest Hospital, Orland Park, Illinois, USA.
- Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, Illinois, USA.
Cite
APA
Fosset, F. T. J., Lucas, B. E. G., Wolsic, C. L., Billhymer, A. C., & Lavergne, S. N. (2023). Retrospective evaluation of hypersensitivity reactions and anaphylaxis in dogs (2003–2014): 86 cases. Journal of Veterinary Emergency and Critical Care. https://doi.org/10.1111/vec.13319
Vancouver
Fosset FTJ, Lucas BEG, Wolsic CL, Billhymer AC, Lavergne SN. Retrospective evaluation of hypersensitivity reactions and anaphylaxis in dogs (2003–2014): 86 cases. Journal of Veterinary Emergency and Critical Care. 2023. doi:10.1111/vec.13319
BibTeX
@article{Fosset2023,
author = {Fosset, Fabrice T J and Lucas, Benjamin E G and Wolsic, Cassandra L and Billhymer, Audrey C and Lavergne, Sidonie N},
title = {Retrospective evaluation of hypersensitivity reactions and anaphylaxis in dogs (2003–2014): 86 cases},
journal = {Journal of Veterinary Emergency and Critical Care},
year = {2023},
doi = {10.1111/vec.13319}
}
EUVIMED